Clinical Trial Update: Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial evaluating a three-drug combination of carboplatin, vinorelbine, and capecitabine in patients with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Capecitabine (capecitabine)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: University of New Mexico | Conditions: Breast, Cancer | Phase 1, Phase 2 | Status: COMPLETED